QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (40) Citing Articles via Google Scholar Google Scholar Articles by Li, Q. Articles by Wilson, W. A. Search for Related Content PubMed PubMed Citation Articles by Li, Q. Articles by Wilson, W. A.

 Previous Article  |  Next Article 

The Journal of Neuroscience, April 15, 2002, 22(8):3070-3080

NMDA Receptor Antagonists Disinhibit Rat Posterior Cingulate and Retrosplenial Cortices: A Potential Mechanism of Neurotoxicity

Qiang Li^{1, 3}, Suzanne Clark^{1, 3}, Darrell V. Lewis², and Wilkie A. Wilson^{1, 3}

Departments of ¹ Pharmacology and Cancer Biology and ² Pediatrics (Neurology), Duke University Medical Center, Durham, North Carolina 27710, and ³ Neurology Research, Veterans Administration Medical Center, Durham, North Carolina 27705

NMDA receptor antagonists produce region-specific neurodegeneration by an undetermined mechanism, but one proposed mechanism involves disinhibition. In certain areas of the brain, NMDA receptors mediate excitatory drive onto inhibitory interneurons. Thus, NMDA receptor/channel antagonists may reduce inhibition (i.e., produce "disinhibition"). If a sufficient level of disinhibition is produced, enhanced vulnerability to excitotoxicity may result. Furthermore, if there are region-specific differences in NMDA antagonist-induced disinhibition, this could underlie region-specific NMDA antagonist-induced neurotoxicity. In the present study, we tested this hypothesis by exposing rat brain slices to the NMDA receptor antagonist dizocilpine maleate (MK-801) and measuring MK-801-induced disinhibition in areas of higher and lower vulnerability to neurodegeneration [posterior cingulate/retrosplenial cortices (PCC/RSC) and parietal cortex, respectively]. Using whole-cell patch-clamp techniques, bicuculline-sensitive GABA_A receptor-mediated IPSCs were measured in biocytin-labeled pyramidal neurons in the PCC/RSC and parietal cortex. In the PCC/RSC, bath-applied MK-801 (10-40 µM) produced disinhibition, shown as a concentration-dependent decrease in spontaneous IPSC frequency and amplitude; MK-801 (40 µM) also reduced evoked IPSC amplitudes. In parietal cortex, MK-801 produced significantly less disinhibition. To determine whether disinhibition is caused by presynaptic or postsynaptic mechanisms, we tested the effects of MK-801 (40 µM) against miniature IPSC (mIPSC) frequency and amplitude in tetrodotoxin (TTX; 0.5 µM)-treated slices and found that MK-801 did not alter mIPSC frequency or amplitude. Taken together, these results suggest that NMDA receptors regulate activity of inhibitory interneurons and, consequently, GABA release in certain cortical areas. This region-specific reduction in inhibitory input to pyramidal cells could underlie the region-specific neurotoxicity of NMDA antagonists.

Key words: MK-801; NMDA receptor; IPSCs; disinhibition; pyramidal cells; interneurons; cingulate cortex

---

Copyright © 2002 Society for Neuroscience  0270-6474/02/2283070-11$05.00/0

This article has been cited by other articles:

				D. L. F. Garden, P. V. Massey, D. A. Caruana, B. Johnson, E. C. Warburton, J. P. Aggleton, and Z. I. Bashir Anterior thalamic lesions stop synaptic plasticity in retrosplenial cortex slices: expanding the pathology of diencephalic amnesia Brain, July 1, 2009; 132(7): 1847 - 1857. [Abstract] [Full Text] [PDF]

				J. A. Lieberman, F. P. Bymaster, H. Y. Meltzer, A. Y. Deutch, G. E. Duncan, C. E. Marx, J. R. Aprille, D. S. Dwyer, X.-M. Li, S. P. Mahadik, et al. Antipsychotic Drugs: Comparison in Animal Models of Efficacy, Neurotransmitter Regulation, and Neuroprotection Pharmacol. Rev., September 1, 2008; 60(3): 358 - 403. [Abstract] [Full Text] [PDF]

				R. M. de Pablos, R. F. Villaran, S. Arguelles, A. J. Herrera, J. L. Venero, A. Ayala, J. Cano, and A. Machado Stress Increases Vulnerability to Inflammation in the Rat Prefrontal Cortex J. Neurosci., May 24, 2006; 26(21): 5709 - 5719. [Abstract] [Full Text] [PDF]

				C. R. Yang and L. Chen Targeting Prefrontal Cortical Dopamine D1 and N-Methyl-D-Aspartate Receptor Interactions in Schizophrenia Treatment Neuroscientist, October 1, 2005; 11(5): 452 - 470. [Abstract] [PDF]

				R. N. Holdefer, J. C. Houk, and L. E. Miller Movement-Related Discharge in the Cerebellar Nuclei Persists After Local Injections of GABAA Antagonists J Neurophysiol, January 1, 2005; 93(1): 35 - 43. [Abstract] [Full Text] [PDF]

				R. M. Harper, P. M. Macey, L. A. Henderson, M. A. Woo, K. E. Macey, R. C. Frysinger, J. R. Alger, K. P. Nguyen, and F. L. Yan-Go fMRI responses to cold pressor challenges in control and obstructive sleep apnea subjects J Appl Physiol, April 1, 2003; 94(4): 1583 - 1595. [Abstract] [Full Text] [PDF]

				L. Madhavan, W. J. Freed, V. Anantharam, and A. G. Kanthasamy 5-Hydroxytryptamine 1A Receptor Activation Protects against N-Methyl-D-aspartate-Induced Apoptotic Cell Death in Striatal and Mesencephalic Cultures J. Pharmacol. Exp. Ther., March 1, 2003; 304(3): 913 - 923. [Abstract] [Full Text] [PDF]

				R. H. Garman Evaluation of Large-Sized Brains for Neurotoxic Endpoints Toxicol Pathol, January 1, 2003; 31(1_suppl): 32 - 43. [Abstract] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help